Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 3;72(44):1190–1196. doi: 10.15585/mmwr.mm7244a3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.

PMC Copyright notice

This figure is a line graph illustrating the estimated coverage with selected individual vaccines and a combined vaccine series by age 24 months, by birth year in the United States, according to the National Immunization Survey-Child, 2012–2022. — Estimated coverage with selected individual vaccines*^,^†^,^§^,^¶^,^**^,^††^,^§§ and a combined vaccine series^¶¶ by age 24 months, by birth year*** — National Immunization Survey-Child, United States, 2012–2022

Abbreviations: DTaP = diphtheria and tetanus toxoids and acellular pertussis vaccine; HepA = hepatitis A vaccine; HepB = hepatitis B vaccine; Hib = Haemophilus influenzae type b conjugate vaccine; MMR = measles, mumps, and rubella vaccine; PCV = pneumococcal conjugate vaccine; VAR = varicella vaccine.

* Includes vaccinations received by age 24 months, except for the HepB birth dose, rotavirus vaccination, and ≥2 HepA doses by 35 months. For all vaccines except the HepB birth dose and rotavirus vaccination, the Kaplan-Meier method was used to estimate vaccination coverage to account for children whose vaccination history was ascertained before age 24 months (35 months for ≥2 HepA doses).

^† Includes children who might have been vaccinated with diphtheria and tetanus toxoids vaccine or diphtheria, tetanus toxoids, and pertussis vaccine.

^§ Includes children who might have been vaccinated with MMR and varicella combination vaccine.

^¶ Hib full series: primary series and booster dose, which includes receipt of ≥3 or ≥4 doses, depending on product type received.

** One dose HepB administered from birth through age 3 days.

^†† Includes ≥2 doses of Rotarix monovalent rotavirus vaccine or ≥3 doses of RotaTeq pentavalent rotavirus vaccine; if any dose in the series is either RotaTeq or unknown, the default is to a 3-dose series. The maximum age for the final rotavirus dose is 8 months, 0 days.

^§§ Influenza vaccine doses must be ≥24 days apart (4 weeks with a 4-day grace period); doses could have been received during two influenza seasons.

^¶¶ The combined seven-vaccine series (4:3:1:3*:3:1:4) includes ≥4 doses of DTaP, ≥3 doses of poliovirus vaccine, ≥1 dose of measles-containing vaccine, the full series of Hib (≥3 or ≥4 doses, depending on product type), ≥3 doses of HepB, ≥1 dose of VAR, and ≥4 doses of PCV.

*** Children born in 2011 are included in survey years 2012, 2013, and 2014; children born in 2012 are included in survey years 2013, 2014, and 2015; children born in 2013 are included in survey years 2014, 2015, and 2016, children born in 2014 are included in survey years 2015, 2016, and 2017; children born in 2015 are included in survey years 2016, 2017, and 2018; children born in 2016 are included in survey years 2017, 2018, and 2019; children born in 2017 are included in survey years 2018, 2019 and 2020; children born in 2018 are included in survey years 2019 and 2020, and 2021; children born in 2019 are included in survey years 2020, 2021, and 2022; data for children born in 2020 are considered preliminary and are from survey years 2021 and 2022 (data from survey year 2023 are not yet available).